HCMT
FATE icon

Highland Capital Management (Texas)’s Fate Therapeutics FATE Stock Holding History

Highland Capital Management (Texas)’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-657,097
Closed -$3.5M – 266
2015
Q3 		$3.5M Sell
657,097
-265,333
-29% -$1.81M 0.1% 164
2015
Q2 		$5.97M Buy
922,430
+594,242
+181% +$3.56M 0.12% 150
2015
Q1 		$1.6M Buy
328,188
+294,913
+886% +$1.46M 0.03% 181
2014
Q4 		$167K Buy
+33,275
New +$147K 0.01% 211

Other funds holding FATE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Highland Capital Management (Texas)'s FATE Position: Q4 2015 in Review

Highland Capital Management (Texas) sold out of Fate Therapeutics (FATE) in Q4 2015, closing a stake of 657,097 shares — an estimated $3.5M sold.

Highland Capital Management (Texas) first reported a position in FATE in Q4 2014 and held it in 4 quarters. The position peaked at $5.97M in Q2 2015. 54 funds tracked by Wall St. Rank hold FATE as of Q4 2015.

  • Highland Capital Management (Texas) reported no remaining Fate Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 657,097 Fate Therapeutics shares in Q4 2015, an estimated $3.5M.
  • Highland Capital Management (Texas) first reported a position in Fate Therapeutics in Q4 2014 and held it in 4 quarters.
  • Highland Capital Management (Texas)'s Fate Therapeutics position peaked at $5.97M in Q2 2015.
  • 54 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2015.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2015, filed 16 Feb 2016.